These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 26674646)

  • 21. Plasma cytokine profiles related to smoking-sensitivity and phenotypes of chronic obstructive pulmonary disease.
    Nakamura M; Nakamura H; Minematsu N; Chubachi S; Miyazaki M; Yoshida S; Tsuduki K; Shirahata T; Mashimo S; Takahashi S; Nakajima T; Tateno H; Fujishima S; Betsuyaku T
    Biomarkers; 2014 Aug; 19(5):368-77. PubMed ID: 24842387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenosine Metabolism in COPD: A Study on Adenosine Levels, 5'-Nucleotidase, Adenosine Deaminase and Its Isoenzymes Activity in Serum, Lymphocytes and Erythrocytes.
    Singh Patidar B; Meena A; Kumar M; Menon B; Rohil V; Kumar Bansal S
    COPD; 2018 Dec; 15(6):559-571. PubMed ID: 30663435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Systemic inflammatory profile of smokers with and without COPD].
    Mosrane Y; Bougrida M; Alloui AS; Martani M; Rouabah L; Bourahli MK; Mehdioui H; Ben Saad H
    Rev Pneumol Clin; 2017 Sep; 73(4):188-198. PubMed ID: 28838624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Interleukin-17 expression and significance in normal lung function smokers and chronic obstructive pulmonary disease patients].
    Zhang JQ; Lao QF; Chu SY; Bai J; Zhong XN
    Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1431-5. PubMed ID: 20646637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of 4-hydroxynonenal in assessment of chronic obstructive pulmonary disease severity].
    Liu H; Xu JY
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Oct; 35(10):758-61. PubMed ID: 23289993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking.
    Nowak D; Kasielski M; Antczak A; Pietras T; Bialasiewicz P
    Respir Med; 1999 Jun; 93(6):389-96. PubMed ID: 10464820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-reactive protein in patients with COPD, control smokers and non-smokers.
    Pinto-Plata VM; Müllerova H; Toso JF; Feudjo-Tepie M; Soriano JB; Vessey RS; Celli BR
    Thorax; 2006 Jan; 61(1):23-8. PubMed ID: 16143583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-18 production and pulmonary function in COPD.
    Imaoka H; Hoshino T; Takei S; Kinoshita T; Okamoto M; Kawayama T; Kato S; Iwasaki H; Watanabe K; Aizawa H
    Eur Respir J; 2008 Feb; 31(2):287-97. PubMed ID: 17989120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolomics analysis identifies sex-associated metabotypes of oxidative stress and the autotaxin-lysoPA axis in COPD.
    Naz S; Kolmert J; Yang M; Reinke SN; Kamleh MA; Snowden S; Heyder T; Levänen B; Erle DJ; Sköld CM; Wheelock ÅM; Wheelock CE
    Eur Respir J; 2017 Jun; 49(6):. PubMed ID: 28642310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum metalloproteinase-9 is related to COPD severity and symptoms - cross-sectional data from a population based cohort-study.
    Linder R; Rönmark E; Pourazar J; Behndig A; Blomberg A; Lindberg A
    Respir Res; 2015 Feb; 16(1):28. PubMed ID: 25849664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial perfusion reserve is impaired in patients with chronic obstructive pulmonary disease: a comparison to current smokers.
    Nakamori S; Onishi K; Ishida M; Nakajima H; Yamada T; Nagata M; Kitagawa K; Dohi K; Nakamura M; Sakuma H; Ito M
    Eur Heart J Cardiovasc Imaging; 2014 Feb; 15(2):180-8. PubMed ID: 23839654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Birth Weight and Smoking on Lung Function in Patients with Asthma, COPD, and Healthy Volunteers.
    Panaszek B; Pawłowicz R; Lindner K; Dobek R; Panaszek K; Obojski A; Rosińczuk J; Ichnowski J
    Adv Clin Exp Med; 2016; 25(6):1207-1213. PubMed ID: 28028975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolomic Profiling Differences among Asthma, COPD, and Healthy Subjects: A LC-MS-based Metabolomic Analysis.
    Liang Y; Gai XY; Chang C; Zhang X; Wang J; Li TT
    Biomed Environ Sci; 2019 Sep; 32(9):659-672. PubMed ID: 31635682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease.
    Eickhoff P; Valipour A; Kiss D; Schreder M; Cekici L; Geyer K; Kohansal R; Burghuber OC
    Am J Respir Crit Care Med; 2008 Dec; 178(12):1211-8. PubMed ID: 18836149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotyping of Chronic Obstructive Pulmonary Disease Based on the Integration of Metabolomes and Clinical Characteristics.
    Kilk K; Aug A; Ottas A; Soomets U; Altraja S; Altraja A
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smokers with COPD Show a Shift in Energy and Nitrogen Metabolism at Rest and During Exercise.
    Holz O; DeLuca DS; Roepcke S; Illig T; Weinberger KM; Schudt C; Hohlfeld JM
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1-13. PubMed ID: 32021139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular profiling of EGFR family in chronic obstructive pulmonary disease: correlation with airway obstruction.
    Anagnostis A; Neofytou E; Soulitzis N; Kampas D; Drositis I; Dermitzaki D; Tzanakis N; Schiza S; Siafakas NM; Tzortzaki EG
    Eur J Clin Invest; 2013 Dec; 43(12):1299-306. PubMed ID: 24147598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Concentration of nitric oxide exhaled air (eNO) in patients with COPD and bronchiectasis].
    Ziora D; Kałuska K; Rauer R; Kozielski J
    Pneumonol Alergol Pol; 2003; 71(9-10):418-27. PubMed ID: 15052978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD.
    Kinnula VL; Ilumets H; Myllärniemi M; Sovijärvi A; Rytilä P
    Eur Respir J; 2007 Jan; 29(1):51-5. PubMed ID: 17050565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exhaled volatile organic compounds discriminate patients with chronic obstructive pulmonary disease from healthy subjects.
    Besa V; Teschler H; Kurth I; Khan AM; Zarogoulidis P; Baumbach JI; Sommerwerck U; Freitag L; Darwiche K
    Int J Chron Obstruct Pulmon Dis; 2015; 10():399-406. PubMed ID: 25759572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.